Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored With the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored With the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award
"Innovation in imaging science is essential for advancing biomedicine," said Dr. Mallick. "I am truly honored to receive this prestigious award from the Academy and join its Council of Distinguished Investigators. This honor is a testament to the advances my lab members, partners, and colleagues have helped make possible."Dr. Mallick to be inducted into the Academy for Radiology and Biomedical Imaging Research's esteemed Council of Distinguished Investigators for his outstanding contributions to medical imaging
Mallick博士因在醫療影像領域做出傑出貢獻，將被選入放射學和生物醫藥影像研究院卓越調查員委員會。
SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or "Nautilus"), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced Nautilus co-founder and Chief Scientist Parag Mallick, Ph.D., was bestowed the 2024 Distinguished Investigator (DI) Award by the Academy for Radiology and Biomedical Imaging Research (the Academy).
2024年10月31日，Nautilus生物技術公司（納斯達克股票代碼：NAUT； 或 "鸚鵡螺體育"），是一家開創性的單分子蛋白質分析平台公司，用於量化蛋白質組，今天宣佈，Nautilus 共同創始人兼首席科學家 Parag Mallick 博士榮獲2024年度放射學和生物醫學影像研究學院（Academy）頒發的傑出研究員（DI）獎。
The Award recognizes Dr. Mallick's notable achievements in the field of imaging research, including his decades-long leadership, high-impact publications, and ongoing research and development contributions.
該獎項表彰了 Mallick 博士在成像研究領域的顯著成就，包括他數十年來的領導、高影響力出版物，以及持續的研究和開發貢獻。
"Innovation in imaging science is essential for advancing biomedicine," said Dr. Mallick. "I am truly honored to receive this prestigious award from the Academy and join its Council of Distinguished Investigators. This honor is a testament to the advances my lab members, partners, and colleagues have helped make possible."
"創新的成像科學對推動生物醫學至關重要，" Mallick 博士說。"能獲得學院頒發的這一殊榮並加入其傑出研究員委員會，我深感榮幸。這一榮譽證明了我的實驗室成員、合作伙伴和同事們幫助實現的進步。"
"Parag continues to prove his unwavering commitment to scientific excellence and the improvement of human health," said Sujal Patel, Chief Executive Officer of Nautilus. "His accomplishments over the course of his career are many, with each bringing our entire industry a step closer to unlocking critical biological insights."
蘇傑爾·帕特爾，鸚鵡螺體育首席執行官說：「帕拉格繼續證明了他對科學卓越和改善人類健康的堅定承諾。他職業生涯中的成就衆多，每一項都讓整個行業更接近於揭示重要的生物信息。」
Dr. Mallick will be inducted into the Academy's Council of Distinguished Investigators during the Annual Meeting of the Radiological Society of North America (RSNA) taking place December 1-5, 2024 in Chicago, Illinois.
Mallick博士將於2024年12月1日至5日在伊利諾伊州芝加哥舉行的北美放射學會（RSNA）年會期間被引入學院的傑出研究員委員會。
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus' mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit .
關於Nautilus Biotechnology，Inc。
鸚鵡螺體育總部位於西雅圖，研發總部位於舊金山灣區，是一家生命科學公司，正在開發階段創建一種用於量化和解鎖蛋白質組複雜性的平台技術。鸚鵡螺體育的使命是通過使蛋白質組 democratizing 訪問蛋白質組，並促進人類健康和醫學的基礎進展。要了解更多關於鸚鵡螺體育的信息，請訪問 .
Media Contact
press@nautilus.bio
媒體聯繫人
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
投資者聯繫方式
investorrelations@nautilus.bio
A photo accompanying this announcement is available at
此公告附帶的照片
譯文內容由第三人軟體翻譯。
